Liu et al (2006) recently showed that in cell line studies for different tissues that in both normal and cancer cells, the loss of BMI-1 led to the upregulation of p16, but with no significant effect on the level of telomerase gene expression. This evidence concerns the gene CDKN2A and cancer.